Security key
09075V102
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Shares outstanding
- 253,647,595
- Total 13F shares
- 53,756,637
- Share change
- +1,917,307
- Total reported value
- $5,723,405,583
- Put/Call ratio
- 125%
- Price per share
- $106.47
- Number of holders
- 255
- Value change
- +$241,986,249
- Number of buys
- 113
- Number of sells
- 132
Report period
Q2 2025
Institutions
255
Top holders
10
BNTX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
BioNTech SE SEC filings
BioNTech SE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075V102
Recent filing periods:
Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Medine GmbH |
13D/G
|
Prof. Ugur Sahin, M.D. |
18%
|
42,178,034
|
$4,386,515,536 | $0 | 31 Mar 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.2%
|
8,159,682
|
$743,020,643 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.9%
|
7,283,411
|
$663,227,406 | — | 31 Mar 2025 | |
| Se Flossbach von Storch |
13F
|
Individual |
1.7%
|
4,259,631
|
$387,881,999 | — | 31 Mar 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.6%
|
4,046,425
|
$368,467,461 | — | 31 Mar 2025 | |
| PFIZER INC |
13F
|
Company |
1.4%
|
3,658,361
|
$333,130,353 | — | 31 Mar 2025 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.71%
|
1,807,232
|
$164,566,545 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.66%
|
1,665,939
|
$151,700,422 | — | 31 Mar 2025 | |
| Capital International Investors |
13F
|
Company |
0.56%
|
1,428,441
|
$130,073,837 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.47%
|
1,195,470
|
$108,859,498 | — | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.35%
|
879,972
|
$80,130,250 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
713,606
|
$64,981,074 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
698,368
|
$63,593,335 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.26%
|
670,955
|
$61,097,534 | — | 31 Mar 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.26%
|
649,284
|
$59,123,801 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
645,142
|
$58,746,630 | — | 31 Mar 2025 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.25%
|
638,099
|
$58,105,295 | — | 31 Mar 2025 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.24%
|
620,766
|
$56,526,952 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.21%
|
544,970
|
$49,624,968 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
493,931
|
$44,977,357 | — | 31 Mar 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.19%
|
478,257
|
$43,542,877 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.17%
|
425,442
|
$38,740,838 | — | 31 Mar 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.16%
|
411,897
|
$36,620,000 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.15%
|
385,668
|
$35,118,928 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
382,979
|
$34,874,068 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
347,727
|
$31,664,021 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.12%
|
316,935
|
$28,860,101 | — | 31 Mar 2025 | |
| LBP AM SA |
13F
|
Company |
0.12%
|
305,221
|
$27,793,425 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
293,776
|
$26,751,242 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.11%
|
289,788
|
$26,388,096 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
270,211
|
$24,605,413 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
270,000
|
$24,586,200 | — | 31 Mar 2025 | |
| Amundi |
13F
|
Individual |
0.11%
|
268,337
|
$24,689,688 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
261,984
|
$23,856,263 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
255,890
|
$23,293,591 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.1%
|
253,460
|
$23,057,595 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
243,468
|
$22,170,196 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
221,190
|
$20,141,562 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.09%
|
218,422
|
$19,889,508 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.08%
|
200,000
|
$18,212,000 | — | 31 Mar 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.08%
|
197,946
|
$18,024,963 | — | 31 Mar 2025 | |
| Asset Managment Groupama |
13F
|
Individual |
0.08%
|
196,544
|
$18,661,853 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.08%
|
190,252
|
$17,174,879 | — | 31 Mar 2025 | |
| Gestion Carmignac |
13F
|
Individual |
0.07%
|
185,877
|
$17,004,672 | — | 31 Mar 2025 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.07%
|
178,997
|
$16,299,467 | — | 31 Mar 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
177,839
|
$16,194,019 | — | 31 Mar 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.07%
|
165,000
|
$15,024,900 | — | 31 Mar 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.06%
|
159,000
|
$14,478,540 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
152,911
|
$13,924,076 | — | 31 Mar 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.06%
|
145,687
|
$13,266,258 | — | 31 Mar 2025 |
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2025
As of 30 Jun 2025,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
255 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,756,637 shares.
The largest 10 holders included
FMR LLC, BAILLIE GIFFORD & CO, FLOSSBACH VON STORCH SE, PRIMECAP MANAGEMENT CO/CA/, Pfizer Inc, T. Rowe Price Investment Management, Inc., Temasek Holdings (Private) Ltd, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, and Capital International Investors.
This page lists
256
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
276
Q2 2025 holders
255
Holder diff
-21
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.